VENKER ERIC sold 42.1% of their position (14.23K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $342.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/3/2026ACC: 0001764013-26-000024
-349.19K
Net shares
Net seller
$8.75M
Total sold
2
Open market trades
0B · 2S
5
Total transactions
368.75K acquired · 717.94K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+368.75K
Price / share
$14.46
Trade value
$5.33M
% of position
New position
4/1/2026
0.00→368.75K
Common Stock
Direct
Shares
−334.96K
Price / share
$25.10
Trade value
$8.41M
% of position
90.8%
4/1/2026
368.75K→33.79K
Common Stock
Direct
Shares
−12.82K
Price / share
$24.04
Trade value
$308.19K
% of position
37.9%
4/2/2026
33.79K→20.97K
Common Stock
Direct
Shares
−1.41K
Price / share
$24.60
Trade value
$34.66K
% of position
6.7%
4/2/2026
20.97K→19.56K
Total
Net shares
+19.56K
Net value
-$3.42M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +368.75K | $14.46 | $5.33M | New position | 0.00 | 368.75K |
| Common Stock Direct | 4/1/2026 | D · Disposition | −334.96K | $25.10 | $8.41M | 90.8% | 368.75K | 33.79K |
| Common Stock Direct | 4/2/2026 | S · Sale | −12.82K | $24.04 | $308.19K | 37.9% | 33.79K | 20.97K |
| Common Stock Direct | 4/2/2026 | S · Sale | −1.41K | $24.60 | $34.66K | 6.7% | 20.97K | 19.56K |
| Total | +19.56K | -$3.42M | ||||||
Derivative Transactions1
Capped Value Appreciation Rights
Direct
Converts to
Common Stock
368.75K shares
Shares
−368.75K
Strike price
14.46
Held after
1.11M
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Capped Value Appreciation Rights Direct | Common Stock368.75K shares | 4/1/2026 | M · Option Exercise | −368.75K | 14.46 | — | 1.11M |